000 03991nam a22004215i 4500
999 _c9482
_d9482
001 9482
003 DE-He213
005 20210511040345.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 170901s2018 gw | s |||| 0|eng d
020 _a9783319605708
024 7 _a10.1007/978-3-319-60570-8
_2doi
040 _aES-MaUEC
_bspa
_dES-VaUE
050 4 _aRC655.49
_bT443 2018 EB
245 1 4 _aThe Bethesda System for Reporting Thyroid Cytopathology:
_bDefinitions, Criteria, and Explanatory Notes
_cedited by Syed Z. Ali, Edmund S. Cibas.
250 _a2nd edition
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2018.
300 _a1 recurso en línea (XV, 236 páginas 224 ilustraciones a color)
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aOverview of Diagnostic Terminology and Reporting -- Nondiagnostic/Unsatisfactory -- Benign -- Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance -- Follicular Neoplasm/Suspicious for a Follicular Neoplasm -- Follicular Neoplasm, Hürthle Cell (Oncocytic) Type/Suspicious for a Follicular Neoplasm, Hürthle Cell (Oncocytic) Type -- Suspicious for Malignancy -- Papillary Thyroid Carcinoma, Variants, and Related Tumors -- Medullary Thyroid Carcinoma -- Poorly Differentiated Thyroid Carcinoma -- Undifferentiated (Anaplastic) Carcinoma and Squamous Cell Carcinoma of the Thyroid -- Metastatic Tumors, Lymphomas, and Rare Tumors of the Thyroid.
520 3 _a The first edition of The Bethesda System for Reporting Thyroid Cytopathology was published in 2010 and has greatly influenced the practice of thyroid cytopathology. The terminology proposed and illustrated in this text has been widely adopted not only in the U.S. but also abroad. It has become an essential text for pathology trainees and practicing pathologists examining thyroid fine needle aspiration (FNA) specimens. Since 2010, there have been a number of important advances in the management of patients with nodular thyroid disease and in the understanding of the biology of thyroid cancer. This new edition includes these advances that impact terminology for reporting thyroid cytopathology. In particular, it incorporates a discussion of the recently implemented and now widespread use of molecular testing of thyroid FNA samples, which has transformed the management of patients with nodular thyroid disease in the U.S.. In addition, this edition accommodates the recent changes to the classification of thyroid cancer, most notably the introduction of a new thyroid diagnosis, that of "non-invasive follicular tumor with papillary-like nuclear features (NIFTP)". Thoroughly revised and updated, The Bethesda System for Reporting Thyroid Cytopathology, Second Edition will provide the reader with a unified approach to diagnosing and reporting thyroid FNA interpretations. It serves as a reference guide not just for pathologists, but also endocrinologists, surgeons, and radiologists.
650 7 _aPatología
_2embne
_9138489
650 7 _aEndocrinología
_2embne
_9139372
650 7 _aTiroides
700 1 _aAli, Syed Z.
_eeditor literario
_0http://id.loc.gov/authorities/names/n2007181685
_0http://viaf.org/viaf/16685583
700 1 _aCibas, Edmund S.
_eeditor literario
_0http://id.loc.gov/authorities/names/n95801266
_0http://viaf.org/viaf/11563726
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_0http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319605692
776 0 8 _iEdición impresa:
_z9783319605715
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-60570-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db